These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19892669)

  • 1. Treatment of cystic fibrosis: time for a new paradigm?
    Bush A
    Chest; 2009 Nov; 136(5):1197-1199. PubMed ID: 19892669
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human DNase in cystic fibrosis.
    Milla CE
    Lancet; 1999 Jul; 354(9176):428. PubMed ID: 10437902
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
    Zach MS
    Thorax; 1996 Jul; 51(7):750-5. PubMed ID: 8882085
    [No Abstract]   [Full Text] [Related]  

  • 4. Question 2: should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
    Badurdeen S; Ross-Russell R
    Arch Dis Child; 2010 Jul; 95(7):562-4. PubMed ID: 20551202
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis and survival in patients with advanced lung disease.
    Dasenbrook EC
    BMJ; 2011 Mar; 342():d726. PubMed ID: 21382942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cystic fibrosis: current therapy. Inhalation therapy with recombinant DNAse].
    Rutishauser M
    Schweiz Med Wochenschr Suppl; 2000; 122():47S-48S. PubMed ID: 12536474
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based medicine in cystic fibrosis: how should practice change?
    Conway SP
    Pediatr Pulmonol; 2002 Sep; 34(3):242-7. PubMed ID: 12203857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of the patient with mucoviscidosis].
    ;
    Rev Mal Respir; 2003 Feb; 20(1 Pt 1):149-57. PubMed ID: 12739564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cystic fibrosis: current treatment and perspectives].
    Rault G
    Soins Pediatr Pueric; 1995; (167-168):12-20. PubMed ID: 8715095
    [No Abstract]   [Full Text] [Related]  

  • 10. DNase in cystic fibrosis: the challenge of assessing response and maximising benefit.
    Innes JA
    Thorax; 1998 Dec; 53(12):1003-4. PubMed ID: 10195066
    [No Abstract]   [Full Text] [Related]  

  • 11. Which DNAse in cystic fibrosis?
    Morice AH
    Lancet; 1993 Sep; 342(8871):624-5. PubMed ID: 8102760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 13. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
    Kling S; Gie RP; Riphagen S
    Pediatr Pulmonol; 1997 Aug; 24(2):124-5. PubMed ID: 9292906
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of adults with cystic fibrosis.
    Smith DL; Stableforth DE
    Br J Hosp Med; 1992 Dec 2-1993 Jan 5; 48(11):713, 717-23. PubMed ID: 1467816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystic fibrosis: molecular aspects and therapeutic prospects].
    Mazza P
    Boll Chim Farm; 1994 Jan; 133(1):35-8. PubMed ID: 8166964
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment and prognosis of massive hemoptysis in cystic fibrosis.
    Stern RC; Wood RE; Boat TF; Matthews LW; Tucker AS; Doershuk CF
    Am Rev Respir Dis; 1978 May; 117(5):825-8. PubMed ID: 655488
    [No Abstract]   [Full Text] [Related]  

  • 17. Cystic fibrosis: diagnosis, treatment, and prognosis.
    Wood RE
    South Med J; 1979 Feb; 72(2):189-202. PubMed ID: 371004
    [No Abstract]   [Full Text] [Related]  

  • 18. [New therapeutic modalities for pulmonary disease in cystic fibrosis].
    Virgilis D; Augarten A; Szeinberg A; Yahav Y
    Harefuah; 1995 Dec; 129(12):569-72. PubMed ID: 8682360
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
    Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A
    JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung inflammation as a therapeutic target in cystic fibrosis.
    Koehler DR; Downey GP; Sweezey NB; Tanswell AK; Hu J
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):377-81. PubMed ID: 15381503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.